June 30, 2016
Horizon Therapeutics filed a patent infringement suit in New Jersey federal court on Thursday, challenging Par Pharmaceutical's efforts to gain regulatory approval for a generic version of Ravicti, a drug that treats inborn urea cycle disorders.